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Introduction: South Africa has a high burden of sexually transmitted infections (STIs) and 
HIV. The role of Gardnerella vaginalis in the development of BV has been disputed after the 
recovery of G. vaginalis from healthy patients and the discovery of new bacteria using 
molecular identification. Infection with HSV has been associated with increased vaginal HIV 
RNA copies and bacterial vaginosis has been implicated as a risk factor for the transmission of 
HIV.  
Methodology: Consenting patients of > 18 years were recruited from two different primary 
health clinics. Microscopy was used to diagnose BV and serology for HIV, HSV-2 and syphilis 
testing. Chlamydia trachomatis and Neisseria gonorrhoeae were detected by BD Probetec, and 
conventional PCR was used for the diagnosis of Trichomonas vaginalis and recognised ulcer 
pathogens. Quantitative bacteriology and HIV viral loads were done using the Applied 
biosystems ABI 7500 Real Time instrument. Immune cells from vaginal tampon specimens 
were analysed using flow cytometry. 
Results: In both clinics, of the discharge pathogens T. vaginalis had the highest prevalence. 
The prevalence of both T. vaginalis and N. gonorrhoeae was significantly higher in Boomstreet 
clinic (p<0.05). The Umlazi D clinic had significantly more patients with BV (p<0.0001) and 
HSV-2 (p<0.05). Of the patients with ulcers, HSV-2 was detected in a one third of the 
specimens in each of the clinics. One patient was diagnosed with lymphogranuloma venereum 
(LGV). The Nugent score group 0-3 was dominated by Lactobacillus spp. while the Nugent 
score group 7-10 was dominated by Gardnerella vaginalis. The group with Nugent score 7-10 
was shown to have significantly higher levels of immune cells that are proposed HIV targets. 
Lactobacillus spp. was associated with the group that was HIV antibody negative and 
Prevotella spp. with the HIV antibody positive group (p < 0.05). Prevotella spp. was not 
associated with shedding of HIV.  The number of bacterial copies of G. vaginalis was 
significantly higher in patients shedding HIV (p < 0.05). In those shedding HSV-2 the number 
of copies of G. vaginalis was also higher but this did not reach statistical significance.  
Conclusion: The trend in STI prevalence was similar to that described previously. We report 
circulating LGV and there is a possible increase in gonorrhoeae which needs to be confirmed. 
The potential pathogenic role of G. vaginalis in BV as well as the increased risk of HIV 






1.1 THESIS OVERVIEW 
1.1.1 Study design and Methodology 
Ethical approval was obtained from the Biomedical Ethics Committee of the University of 
KwaZulu-Natal (ethics number: BE475/14). Informed consent was given by all participants for 
the collection of specimens for research and diagnostic testing. Patients over the age of 18 
presenting with vaginal discharge were recruited from the Boomstreet and Umlazi D Clinic 
which are primary health care (PHC) clinics situated in KwaZulu – Natal. These sites were 
chosen for convenience as previous studies by this same research group utilized these study 
sites and both staff and patients were accustomed to this study type. Pregnant women were 
excluded to avoid that patients would make a perceived  link between participating in the study 
and adverse pregnancy outcome. 
 PHCs service the general population and employs syndromic management. As it is not a 
facility which treats patients for specific conditions, namely patients at high risk for STIs and 
BV, the data from this cohort is thus representative of the general South African population. 
 An illustration of the methodology is shown in Figure 1. A detailed description of the 




Figure 1: Diagrammatic presentation of methodology 
 
1.1.2 Structure of PhD Thesis 
 
This PhD thesis is structured according to the guidelines stipulated by the College of Health 
Sciences at the University of KwaZulu-Natal for the thesis by manuscript format. Each of the 3 
manuscripts’ are formatted according to the journal to which they are submitted. The thesis is 
guided by the following chapters: 
 
Chapter 1: This chapter is a review of the  literature and a presentation of the rationale of the 
study. The association of bacterial vaginosis associated bacteria in the transmission of HIV is 
described. Reported in vitro and in vivo observations define the vaginal immune response to 
associated bacteria, the effect of bacterial metabolic products on the vaginal microbiome and 
the relative risk of HIV transmission. 
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Chapter 2: This chapter is entitled: “Prevalence of sexually transmitted diseases in women 
in KwaZulu-Natal” which has been submitted to The Journal of Sexually Transmitted 
Infections and is currently under review (sextrans-2017-053338). The article details the 
geographical location of 2 primary healthcare clinics in Kwa-Zulu Natal from which patients 
were recruited. It describes the prevalence of sexually transmitted infections in each of these 
clinics and underscores the differences between the two. Additionally, the trend in STIs among 
women presenting with vaginal discharge in KZN over the last 26 years is highlighted and 
placed in the context of what is known for South Africa as a whole. 
Chapter 3: In the previous chapter the STI burden of N. gonorrhoeae and T. vaginalis was 
significantly higher in the Boomstreet clinic while bacterial vaginosis and HSV-2 was higher in 
Umlazi D clinic. Infection with HIV remained constant. Literature supports the idea that 
bacterial vaginosis increases the risk of HIV transmission. The manuscript that forms this 
chapter focuses on a subset of women from the Umlazi clinic without a detectable STI. The 
bacterial morphotypes associated with bacterial vaginosis as identified by microscopy are 
described as well as the immune response related to both bacterial morphotypes and BV score 
in relation to HIV transmission. The manuscript in this chapter is entitled: “Gardnerella 
vaginalis and immune response in patients with symptomatic bacterial vaginosis” has been 
submitted to the Journal of Medical Microbiology and is currently under review (JMM-D-17-
00465) 
Chapter 4: Chapter 2 identified a group of symptomatic women attending a PHC in Umlazi in 
whom incident bacterial vaginosis and HSV-2 were significantly higher than in women 
attending a PHC in Boomstreet. The literature reports that HSV-2 increases the shedding of 
HIV. In chapter 3 the group with Nugent score indicative of BV had the highest relative 
percentage of G. vaginalis. It was found that women with vaginal flora dominated by G. 
vaginalis elicit an immune response with cell types that favor HIV transmission. The 
manuscript that embodies chapter 4 correlates the most frequently observed bacteria and the 
different Nugent score groups to the shedding of HSV-2 and HIV. The manuscript that makes 
up this chapter is entitled: “Increased shedding of HIV and HSV-2 in patients with 
bacterial vaginosis is associated with high bacterial load of Gardnerella vaginalis” has been 
submitted to the Journal of Sexually Transmitted Diseases and is currently under review. 
Chapter 5: In this final chapter the relevant finding of the project in context with literature are 






Bacterial vaginosis (BV) is characterised by a decrease in the amount of Lactobacillus species 
and an overgrowth of otherwise commensal bacteria. It is not considered a sexually transmitted 
infection although it shares many characteristics with this group of infections. It is a frequently 
occurring condition. The standard treatment is metronidazole. Recent molecular techniques 
have led to the identification of non-culturable bacteria such as Atopobium vaginae found to be 
resistant to metronidazole. Atopobium vaginae had a significantly higher prevalence in patients 
with BV as opposed to patients without, (Bradshaw et al. 2006), its resistance to metronidazole 
(Ferris & Masztal 2004) makes it an unlikely candidate as the cause of BV.  
BV has been found to be associated with an increased risk of HIV1 transmission from female to 
male partners, (Cohen et al. 2012). Many studies suggest that BV associated organisms or their 
fermentation products increase propagation of HIV, (Cohen et al. 2012; Graham et al. 2013)  In 
an in vitro study the expression of HIV was upregulated by Peptostreptococcus 
asaccharolyticus, Prevotella bivia, Streptococcus agalactie, and Streptococcus constellatus. 
However, Lactobacillus acidophilus did not upregulate the expression of HIV1, (Petrova et al. 
2013). There is a greater diversity of microbial flora in HIV positive patients presenting with 
BV as compared to HIV negative patients with the same condition. In a separate study 
researchers found Propionibacteriaceae, Anaerococcus, and Citrobacter only in the HIV 
positive group with BV. These were absent in the HIV negative group and the HIV positive 
group without BV, (Spear et al. 2008). 
The vaginal flora in healthy women has an abundance of Lactobacillus spp. that produce L-
lactic acid which inhibits many other microbial species, (O’Hanlon et al. 2011). In addition, 
other studies have shown that cervico-vaginal mucus from women with a lactobacillus 
dominant vaginal microbiome was able to trap HIV allowing it to move 1000 fold slower than 
in water, (Lai et al. 2009). There is a proposed mutualistic relationship between Prevotella spp, 
a BV associated bacterial species producing butyric and succinic acid, and Gardnerella 
vaginalis as demonstrated by ammonia flow from Prevotella to Gardnerella, (Pybus & 
Onderdonk 1997). Butyric acid producing organisms have been shown to support the 
replication of HIV and its progression to AIDS, (Imai et al. 2009). Butyric acid has also been 
proposed to induce reactivation of latent HIV1 provirus, (Kenichi & Kuniyasu 2013). 
Therefore, the condition of bacterial vaginosis potentially increases the risk of transmission of 




With reference to pH changes in the vaginal environment brought on by BV associated 
bacteria, the range varies from an acidic pH of 4.5 to higher pH levels relative to colonisation 
by the different bacterial populations. Ongradi et al, (1990), found that infection of monocyte 
derived dendritic cells with HIV was inhibited at pH 5.7 when incubated for 2 hours. However, 
viral inactivation was achieved in 20 minutes when incubated at pH 5.4. Using a mouse model 
Olmsted et al, (2005) demonstrated a loss of motility of macrophages, monocytes and 
lymphocytes at a pH below 6, while T-lymphocyte activation was decreased at a pH of 4.5, 
thereby limiting the susceptibility of lymphocytes to HIV infection . Therefore it is important to 
determine the different bacterial species contributing to bacterial vaginosis and their effect on 
the pH of the vaginal microenvironment. 
BV associated bacteria have been shown to affect immune responses, one effect being 
prevention of phagocytosis, (Mirmonsef et al. 2011). There is an abundance of macrophages 
present in mucosal sites. These macrophages are believed to harbour HIV and maintain a 
reservoir of infection, (Sharova et al. 2005). Bacterial vaginosis associated bacteria are known 
to produce short chain fatty acids such as butyric acid, acetic acid, etc. While the effect in the 
genital tract of these short chain fatty acids is unclear, investigation in the gut have revealed 
that these short chain fatty acids increased the production of pro-inflammatory cytokines by 
monocytes, (Mirmonsef et al. 2011). 
In the study by Cassol et al, (2013) M2a monocyte derived macrophages were shown to express 
high levels of DC-SIGN which resulted in the increased ability of M2a to bind to HIV and 
become infected. This resulted in the transmission of virus to CD4+ T-cells despite low 
expression. The polarization of macrophages to M2a stimulation and the subsequent 
upregulation of DC-SIGN favor a TH2 response resulting in increased infectivity and 
replication of HIV 1.   
In vitro experiments by St. John et al, (2007) found that vaginal fluids from patients with 
bacterial vaginosis activated and induced maturation of monocyte derived dendritic cells. They 
further demonstrated an increased production of IL12 when monocyte derived dendritic cells 
were exposed to cervical lavage fluid of patients with bacterial vaginosis. It is well documented 
that HIV binds receptors on dendritic cells, (Geijtenbeek et al. 2000). Stimulation of dendritic 
cells by BV associated bacteria drives maturation of these cells which then travel to the lymph 
nodes to transmit the virus to CD4+ T cells.  
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Microscopy remains the gold standard in laboratory diagnosis of BV. While the standardised 
scoring system by Nugent et al, 1991 is widely used, it is based on the assumption that 
Lactobacillus is dominant in healthy women while the increased presence of Gardnerella 
vaginalis is weighted heavily in patients with BV. Studies have reported asymptomatic women 
with a vaginal environment not dominated by lactobacillus, (Anahtar et al. 2015; Ravel et al. 
2011). Advancement in microscopic techniques such as Fluorescent In Situ Hybridisation 
(FISH) have allowed for morphological characterisation of non culturable organisms identified 
by molecular techniques, (Fredricks et al. 2005). 
Due to the growing evidence that bacterial vaginosis may be associated with an increased risk 
of HIV transmission and disease progression, in this study we aimed to morphologically 
identify bacterial types in a cohort of patients presenting with vaginal discharge regardless of 
HIV status. Quantifying the identified bacterial types will provide information regarding the 
dominant bacterial populations within a South African cohort of BV patients. 
In addition, we looked at the viral load in the vaginal environment to determine whether a 
specific population of bacteria increased HIV shedding. By evaluating the presence of the 
different immune cells in vaginal fluid we plan to elucidate the immune response in patients 
representing the three states described by Nugent et al, (1991). 
 
1.3 LITERATURE REVIEW 
 
1.3.1 Pathogenesis of Bacterial Vaginosis 
 
Bacterial vaginosis (BV) is defined in two different ways. The first one is mainly based on 
clinical signs and symptoms known as Amsel’s criteria, (Amsel et al. 1983) The second one is 
based on observations regarding the composition of the vaginal microbiome, observed on a 
Gram stained smear. The most frequently used score system is known as Nugent’s criteria, 
(Nugent et al. 1991) The microscopic definition identifies more women as having BV than the 
clinical definition. The vaginal microbiome is complex in its composition and its regulation to 
maintain a harmonized environment. Several studies have focused on the pathogenesis of BV 
and although a number of organisms have been implicated, no single organism has been 
identified as the causative agent. The mainstay in the development of BV is the shift in 
colonization with Lactobacillus spp. to other bacterial morphotypes, (Biagi et al. 2009). Some 
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women are symptomatic presenting with malodorous discharge, other women remain 
asymptomatic for reasons unknown, (Marrazzo 2011). 
 
1.3.1.1 Factors associated with a ‘healthy’ vaginal microbiome 
 
A normal, healthy vaginal microbiome is thought to comprise predominantly of Lactobacillus 
spp. In such women, the microbiome is dominated by lactic acid producing bacteria which 
acidify the vaginal environment to pH 3.5 to 4.5, (Aldunate et al. 2015).  Asymptomatic women 
of different ethnic groups from North America were reported to be colonised by different 
Lactobacillus spp, (Ravel et al. 2011). This differential species dominance accounted for 
varying pH of the vaginal contents. Anahtar et al, (2015), in their study population of HIV 
negative asymptomatic Black women from South Africa found that only a minority had 
lactobacillus dominant vaginal microbiomes. Ravel et al, (2011), reported that 61.9% of their 
population of Black women in the US had lactobacillus dominance while 38.9% had a diverse 
microbial community. Lactobacillus dominance was found in 59.6% of Hispanic women. The 
authors concluded that in Black as well as Hispanic women the absence of a dominant 
lactobacillus community represents a normal vaginal state. 
 
1.3.3 Shift in bacterial composition and the development of bacterial vaginosis 
 
When there’s a significant reduction in lactic acid producing Lactobacillus spp. and an increase 
in other bacteria, more especially anaerobic bacteria, the vaginal pH increases and there is 
development of BV. The increase in pH is attributed to the short chain fatty acids produced by 
anaerobic bacteria, (Aldunate et al. 2015).  
 
Biagi et al, (2009), found a decrease in lactobacillus DNA in asymptomatic BV patients when 
compared to patients without BV and those with Candida albicans infection.  Bacterial DNA of 
the BV associated anaerobes was increased in patients with asymptomatic BV. Their analysis 
showed synergistic relationships with increased DNA of different anaerobes in BV but could 
not elucidate a predominant bacterial type. They also found that the lactobacillus dominance 




Early studies attributed the shift to BV to the presence of Gardnerella vaginalis, (Gardner & 
Dukes 1955). The study of asymptomatic  South African women by Anahtar et al, (2015) 
found only 37% had lactobacillus dominant communities and 45% of the remaining 63% had 
G. vaginalis dominance.  
 
The frequent isolation of G vaginalis from healthy women, (Aroutcheva et al. 2001) throws 
doubt on the perception that this organism is the single organism responsible for the condition 
of bacterial vaginosis. However, in healthy patients the presence of G. vaginalis is present in 
smaller quantities as opposed to patients with BV indicating that bacterial load plays a role in 
BV, (Ratnam & Fitzgerald 1983). Different strains of G. vaginalis have been found to produce 
substances that act either as antagonists suppressing the growth of other bacteria or allow a 
synergistic relationship increasing the bacterial diversity associated with BV, (Teixeira et al. 
2010). 
 
In the study by Anahtar et al, (2015) the genus Prevotella was found to be present in microbial 
communities in the cohort of women with the greatest bacterial diversity .  
Prevotella  intermedia is associated with periodontal disease, (Yamanaka et al. 2009) and much 
like BV the anaerobic environment in the mouth allows for propagation of a diverse group of 
anaerobes. Their metabolic products influence the pH of the environment. Guan et al, (2006) 
found that P. intermedia was able to optimally degrade hemoglobin at pH 5.0, however 
degradation activity was observed over a wide pH range. Degradation of hemoglobin is 
essential for its survival as the organism is unable to produce its own source of heme. In 
addition P. intermedia was found to produce succinate, acetate and formate. The authors 
associated the production of the fatty acids with a drop in pH observed during bacterial growth. 
They concluded that the virulence of P. intermedia is based on the production of metabolic 
products, which are capable of decreasing the pH to levels which are favorable to the 
proteolytic enzyme required for degradation of hemoglobin. A similar mechanism can play a 
possible role in the development of BV.  
In vitro experiments suggested a symbiotic relation between Prevotella bivia and G. vaginalis. 
Ammonia rich supernatants from P. bivia cultures were able to stimulate the growth of G. 




1.3.2 The vaginal immune response 
 
The female genital tract is under constant microbial challenge due to changes in diversity 
brought on by hormones, age, sexual activity etc. Anahtar et al, (2015), found that BV in 
general is not an accurate predicator of a specific inflammatory response. Instead, specific 
bacteria are capable of eliciting an immune response. In vitro analysis using a vaginal epithelial 
cell line identified four key bacteria showing significant differences in inflammatory cytokine 
production when compared to Lactobacillus crispatus.  Prevotella amnii was found to induce 
significant levels at very low colonies numbers, (Anahtar et al. 2015). 
Mice were infected with either exopolysaccharides (EPS) producing P. intermedia or non-EPS 
producers. The authors found that the EPS producing P. intermedia were phagocytosed less 
frequently than non-EPS producers indicating an ability to evade the immune response, 
(Yamanaka et al. 2011). In the vaginal tract, Prevotella spp. is present consistently. This 
indicates that the BV associated Prevotella spp. is able to evade the immune response, 
conserving their presence in the vaginal tract.   
 
The pro inflammatory cytokines Il6 and IL8 as well as IL1 RA and the inflammatory cytokine 
MIF had higher expression in the female reproductive tract (FRT) cell lines (VK2, Ect1 and 
END1) when subjected to infection with Atopobium vaginae and G. vaginalis as compared to 
L. johnsonii.  A. vaginae induced greater cytokine expression than G. vaginalis and the 
endocervix cell line END1 showed higher expression than the other epithelial cell lines, (Eade 
et al. 2012). This indicates that the FRT produces varying immune response relative to the type 
of epithelial cell present. 
 
1.3.3 The association of BV in the transmission of HIV 
 
The microbiological definition of BV is a shift in the vaginal microbiome resulting in a 
decrease of the amount of Lactobacillus spp. and an increase in anaerobic bacteria. 
Lactobacillus spp. are known to produce lactic acid capable of acidifying the vaginal 
environment to a pH that is not suitable for growth of other bacterial types, (Matu et al. 2010). 
Lactic acid rich cervical mucus has also been shown to trap HIV, (Lai et al. 2009). 
Asymptomatic ‘healthy’ women in South African  have been shown to have a polymicrobial 
vaginal ecosystem, (Anahtar et al. 2015). The absence of lactobacillus dominance means a 
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decrease in lactic acid concentration and consequently in vaginal acidity. This in turn, results in 
greater infection capability and transmission of HIV, (Cone 2014). 
 
A study of Rwandan sex workers showed that women having a lactobacillus dominant 
cervicovaginal micobiome were less likely to have STIs or HIV. Additionally, HIV positive 
women who had a high diversity cervicovaginal microbiome had higher detectable levels of 
HIV RNA, (Borgdorff et al. 2014). In the study by Anahtar et al, (2015), the group displaying 
high levels of pro-inflammatory cytokines also had significantly activated CCR5+CD4+ T 
cells. This group comprised 50% of BV positive women as diagnosed by Nugent’s scoring and 
included the presence of the anaerobic bacterium belonging to the genus Prevotella. An in vitro 
experiment showing the adhesion capacity of different strains of P. bivia to a cervical epithelial 
cell line (HeLa) showed a varying degree of invasion between strains. The strains with the 
highest invasion capacity was associated with increased expression of IL6 and IL8, (Strömbeck 
et al. 2007). Interleukin 6 has been reported to upregulate the expression of HIV in monocyte 
derived macrophages (MDM), (Poli et al. 1990) while IL 8 was shown to increase the 
replication of HIV in vitro within MDM and peripheral blood lymphocytes, (Lane et al. 2001). 
 
Some species of Prevotella including the periodontal pathogen P. intermedia were found to 
produce EPS, which represents a virulence mechanism. The authors reported that EPS 
producing strains of P intermedia were capable of producing abscesses in mice at much lower 
inoculum than non-EPS producers, (Yamanaka et al. 2011).  Microscopic observation of 
biofilms on vaginal smears is a characteristic feature of BV. Biofilm formation is linked to the 
presence of bacteria capable of producing EPS, (Ghafoor et al. 2011). There is a likelihood that 
BV associated EPS producing Prevotella spp. could produce abscesses in the genital region.  
 
The presence of bacteria associated with bacterial vaginosis in particular G. vaginalis and 
Mycoplasma hominis correlated with increased HIV RNA levels in CVL specimens, (Sha et al. 
2017).  A study of African couples found that the hazard ratio of men who acquired HIV 
infections was higher if their partner had BV compared to when the female partner had normal 
vaginal flora. BV was associated with an estimated three fold increased risk of HIV 





1.3.4 Clinical and Laboratory characteristics of Bacterial Vaginosis 
 
1.3.4.1 Clinical Diagnosis 
 
Clinically the diagnosis of bacterial vaginosis is based on Amsel’s criteria.  This includes a set 
of 4 criteria of which 3 should suffice to diagnose BV. These criteria are the presence of a thin 
white homogenous vaginal discharge, vaginal pH greater than 4.7 but not higher than 5.5, a 
malodorous smell similar to that of rotten fish on the addition of 10% potassium hydroxide and 
the presence of ‘clue cells’ on wet prep microscopy which are small nucleated mature epithelial 
cells covered with bacteria, (Amsel et al. 1983). 
 
1.3.4.2 Microscopic diagnosis of Bacterial Vaginosis 
 
Bacterial Vaginosis (BV) has for a long time been defined as the decrease of the usually 
dominant Lactobacillus spp. and an increase of different bacterial morphotypes. Spiegel et al, 
(1983) found an inverse relationship between lactobacillus and gardnerella morphotypes during 
microscopic interpretation of vaginal smears. They proposed a grading system which defined 
healthy as those patients having 3 to 4+ lactobacillus regardless of the presence of gardnerella, 
while BV was the observation of reduced lactobacillus i.e lower than a score of 3 accompanied 
by mixed flora. This method had 100 percent agreement to clinical diagnosis of BV. 
 
Later, Nugent et al, (1991) proposed a standardized scoring system. This system of grading 
followed that of Spiegel et al, (1983).  This scoring was centered on the notion that 
Lactobacillus spp. was dominant in a ‘normal’ vaginal smear. Decreasing numbers of 
lactobacillus allows proliferation of ‘other’ morphotypes resulting in a shift from normal to 
intermediate finally resulting in bacterial vaginosis. This scoring system is still widely used 
today for the laboratory diagnosis of BV. 
 
Begum et al, (2011) compared the use of acridine orange staining to Amsel’s criteria and 
Nugent’s scoring for the diagnosis of BV. This again was based on the presence of clue cells 
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which are epithelial cells covered with predominantly gardnerella.  Gardnerella on epithelial 
cells stained orange yellow on the green epithelial cells.  This stain correlated with Amsel’s 
clinical criteria for the diagnosis of BV. 
1.3.4.3 Molecular identification of bacterial types 
 
Numerous studies have characterized the vaginal flora using molecular techniques, (Fredricks 
et al. 2005; Ling et al. 2010). In patients that lacked symptoms associated with BV the 
dominant bacterial type detected by 16S rDNA PCR was Lactobacillus spp. Bacterial 
sequences showing the progression to a bacterial vaginosis state in 2 asymptomatic patients 
who had a combination of Bacterial Vaginosis Associated Bacteria (BVAB) bacteria were 
detected by PCR at baseline. Using FISH, BVAB showed distinct morphological characteristics 
that separates them from other anaerobes and were also seen attached to epithelial cells in a 
way suggestive of clue cells, (Fredricks et al. 2005). The presence of Atopobium vaginae and 
Gardnerella vaginalis at a concentration of ≥108 and 109 copies /ml were shown to be 
diagnostic of BV, (Menard et al. 2008) and high species diversity was associated with bacterial 
vaginosis.  While a number of bacteria had a high relative abundance in patients with BV, 
bacteria designated BVAB 1, 2 and 3 were specific to bacterial vaginosis.  
The relative abundance of Lactobacillus spp. is greater in healthy women than in patients with 
BV. Additionally there is enriched bacterial diversity in patients with BV, (Dols et al. 2016). 
The evaluation of bacterial diversity and decreased lactobacillus concentration could be used 
for diagnosis of BV. However; in resource poor countries this molecular approach would not be 
practical. 
 
1.3.4.4 Presence of metabolites 
 
Short chain fatty acids are reported in high concentrations in patients with BV. In an in vitro 
experiment by Al-Mushrif et al, (2000) succinic acid was shown to inhibit chemotaxis in 
monocytes derived from fresh human blood and MonoMac 6 cell line while lactic acid showed 
no inhibition. Gas chromatography analysis of bacterial culture supernatants showed that 
Lactobacillus spp. produced the highest level of lactic acid while Prevotella spp. and 
Mobiluncus spp. produced the greatest amount of succinic acid. Lactic acid was significantly 
decreased in patients with BV and succinic acid was significantly higher in patients with BV 
compared to healthy patients and those belonging to the intermediate group, (Al-Mushrif et al. 
2000). In 1989, A.W Sturm reported the inhibition of white blood cell chemotaxis by 6 
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succinate producing anaerobes, with the greatest effect seen in the bacterial isolates producing 
the largest amount of succinate. The author postulated that non-specific vaginitis was likely 
caused by Bacteroides ureolyticus and Mobiluncus spp. due to its higher succinate production 

























1.4 AIMS, OBJECTIVES and HYPOTHESIS 
 
Aim 
To quantify bacterial genera representing the identified bacterial morphotypes in black South 
African women with vaginal discharge and to determine the effect of these microbes on HIV 
shedding and on the vaginal immune response. 
Objectives 
1. To determine the burden and aetiology of sexually transmitted infections (STI) in an 
urban population of Black South African women presenting with vaginal discharge  
2. To determine by Gram stain microscopy the most frequently observed bacterial 
morphotypes in these women 
3. To quantify using genus specific primers the bacteria representing the  identified 
morphotype  
4. To determine by means of flow cytometry the vaginal cellular immune response  
5. To determine if there is an association between a specific bacterial genus, the presence 
of HIV infection and vaginal HIV and HSV-2 shedding  
 
Hypothesis 
Gardnerella vaginalis initiates a mucosal immune response in the cervico-vaginal system that 
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South Africa is a developing country in which syndromic management is used to treat patients. 
The effectiveness of which is determined by the selection of antimicrobials based on local 
prevalence of the pathogen and the drug susceptibility profile. We report on aetiology of 
sexually transmitted infections in females presenting with discharge at two primary healthcare 
clinics (PHC) in KwaZulu-Natal. 
Methods 
Consenting patients > 18years were recruited. Microscopy was used to diagnose BV and 
serology for HIV, HSV and syphilis testing. Chlamydia trachomatis and Neiserria gonorrhoeae 
were detected by BD Probetec, and conventional PCR was used for the diagnosis of 
Trichomonas vaginalis and the recognised ulcer pathogens. 
Results 
In both clinics, of the discharge pathogens T. vaginalis had the highest prevalence. T. vaginalis 
and N. gonorrhoeae were significantly higher in the clinic situated at a taxi rank (p<0.05). The 
clinic in a residential area had significantly more patients with BV (p<0.0001) and HSV-2 
(p<0.05). Of the patients with ulcers, HSV-2 was detected in one third of the specimens in each 
of the clinics. One patient was diagnosed with lymphogranuloma venereum (LGV). 
Conclusion 
There is a possible rise in gonorrhea. The prevalence of N. gonorrhoeae seen at the clinic at the 
taxi rank is higher when compared to previous reports on STI prevalence in South Africa. 
There is also evidence of circulating LGV. 
 
Key words: STI, prevalence, syndromic management 
 
Key messages:  
 Prevalence of STIs and their aetiology differ between clinics depending on the location 









The outcome of syndromic management (SM) of symptomatic sexually transmitted infections 
(STIs) depends on the accurate recognition of the syndrome,[1-2]. While the recognition of 
genital ulcer syndromes and male urethritis is highly accurate, this is not so for non-ulcerative 
STIs in women. Symptoms and signs of this syndrome include discharge from cervix and/or 
vagina, vulvo-vaginal itch , dysuria and lower abdominal pain,[3-4].  
Women presenting with such symptoms to a primary health care clinic (PHC), are routed to the 
sexually transmitted diseases (STD) section of these facilities. The differential diagnosis for 
these symptoms includes sexually transmitted infections, non-sexually transmitted infections 
e.g. yeast vaginitis, malignancies, urinary tract infections or physiological discharge. Most 
patients, who present to a STD facility with genital ulcer disease and men with urethritis, are 
infected with a STI pathogen. In contrast, only a subset of women with non-ulcerative genital 
disease will have a STI. 
Antimicrobial treatment for the different syndromes should be based on local data with respect 
to prevalence of the different pathogens and their susceptibility profile. Since these data change 
over time regular surveillance needs to take place. We report on the aetiology of female 
discharge syndrome in two different PHCs in KwaZulu-Natal. 
 
MATERIALS AND METHODS 
 
Patient recruitment and specimen collection 
Consecutive consenting patients presenting with vaginal discharge were recruited on weekdays 
between 8:00 am and 12:00 from May till September 2014 at Boomstreet Clinic in 
Pietermaritzburg and from October till December 2014 at Umlazi D clinic in Durban in 
KwaZulu-Natal, South Africa. These clinics were chosen for convenience as both clinics had 
been used for previous studies and staff and patients were accustomed to this type of project. 
Both are PHCs with an annual number of patients of 258 236 and 152 615 respectively. Ethics 
was approved by the Biomedical Research Ethics Committee of the University KwaZulu-Natal. 
A vaginal smear was prepared by inserting a Dacron swab on a rigid shaft about 5 cm into the 
vagina, after which it was withdrawn while rotating. The swab containing the vaginal content 
was rolled onto a glass slide, thereafter placed into Diamonds media.  
If an ulcer was observed, the slough was removed with dry sterile gauze and the resulting 
exudate was collected with a Dacron swab. The swab was placed into 1ml of PBS. A glass slide 
was placed onto the ulcer to prepare an impression smear. 
A speculum was inserted into the vagina and the endocervical content was collected by 
inserting a female Probetec swab. A New York City (NYC) agar plate was inoculated on site 




Venous blood was collected from consenting patients for antibody tests. 
Microscopic analysis 
Vaginal smears were Gram stained and viewed by light microscopy using 1000x magnification 
for the diagnosis of BV.  Slides were scored by 2 independent, trained readers using Nugent’s 
criteria,(5). Discrepant scores were re-evaluated. 
The impression smears were stained using a modified Giemsa stain and viewed using 1000x 
magnification for the presence of Donovan bodies. 
The inoculated Diamonds medium was incubated at 37°C. After approximately 48 hours some 
medium was collected from the lower half of the broth column to produce a wet prep. This was 
examined under 400 x magnification for the presence of Trichomonas vaginalis. Negative 
cultures were re-incubated and the examination was repeated daily for another five days. 
Neisseria gonorhoeae culture 
Inoculated New York City ( NYC) plates were streaked to achieve single colonies and 
incubated for 48 hours at 37°C in air with 5 % CO2 and saturated water vapour. Suspected 
colonies were tested for oxidase activity and oxidase positive colonies were subcultured. 
Identification to species level was done by Gram staining, catalase, oxidase and the production 
of acid from glucose. 
Antibody detection tests 
The Core 1 step HIV rapid test was used for the diagnosis of HIV1 and HIV2.  The rapid 
plasma reagin test (RPR), (BD diagnostics, Sparks, USA) was used as a screening test for 
syphilis. Positive RPR tests were confirmed using the Treponema Pallidum Haemagglutination 
assay (TPHA), (Omega Diagnositics, Alva, United Kingdom).  The Viricell HSV-2 IgG kit 
(Viricell, Granda, Spain) was used to detect antibodies against Herpes simplex virus type 2 
(HSV-2). All these tests were performed as per manufacturer’s instructions. 
Molecular diagnostic testing 
The endocervical swabs were processed using the BD Probetec ETAmplified DNA Assay 
(Becton Dickinson, New Jersey, USA) using Strand Displacement technology to detect N. 
gonorrhoeae and C. trachomatis,(6). T. vaginalis was detected by conventional PCR,[6-7] 
using the same DNA. 
To release the ulcer material into the PBS, the swab was rotated against the side of the tube.  
DNA was isolated from 200 µl of the fluid using the QiaAmp DNA isolation mini kit (Qiagen, 
Hilden, Germany) following the manufacturer’s instructions. DNA was eluted in 100 µl AE 
buffer.  Extracted DNA was used as template for detection of Treponema pallidum, 
Haemophilus ducreyii, HSV-2,(7) and C. trachomatis,(8) by conventional PCR. 
Statistics 
 
Prevalence of infections is reported as the proportion of women with any one of the STIs or 
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BV. Differences between sites were assessed using the chi square test and, when applicable, 




A total of 628 patients between the ages of 18 and 64 years were recruited from the two clinics: 
373 (59%) and 255 (41%) patients at Boomstreet Clinic and Umlazi D clinic respectively. 
There were no differences in race, economic status or age between participants of the two clinic 
sites. At Boomstreet Clinic, 156 /373 (42%) were infected with one or more discharge 
pathogens, excluding HIV and BV compared to 75/255 (29%) at Umlazi D Clinic (p=0.002). In 
both clinics, T. vaginalis was the most frequently observed pathogen, followed closely by N. 
gonorhoeae and C. trachomatis (Table 1). The prevalence of T. vaginalis and N. gonorrhoeae 
was significantly higher at Boomstreet Clinic, while there was no difference between the two 
clinics for C. trachomatis (Table 1). There were significantly more patients with BV at Umlazi 
D as compared to Boomstreet (p< 0.0001). The prevalence of HSV-2 but not HIV was also 
significantly higher in Umlazi D (Table 1). At Boomstreet four cases of active syphilis were 
diagnosed with only one at Umlazi D. 
Table 1: Prevalence of STIs in women presenting with vaginal discharge at two PHCs in 
KZN 
  Boom street clinic Umlazi clinic   
  n = 
no. (%) 
positive n = 
no. (%) 
positive p value 
N. gonorrhoeae 372 66 (17.7) 253 27 (10.7) 0.01 
C. trachomatis 372 53 (14.2) 253 28 (11.1) 0.25 
T. vaginalis 373 79 (21.2) 255 32 (12.5) 0.005 
BV > 7 373 164 (43.9) 255 153 (60) 
< 
0,0001 
Syphilis serology >1:8; TPHA 
confirmed 99 4 70 1 0.82 
Syphilis serology  TPHA 
confirmed 99 9 70 2 0.80 
HSV antibodies 99 66 (66.6) 68 55 (80) 0.04 
HIV antibodies 99 60 (60.6) 70 45 (64.3) 0.98 
n= the number of patients tested in each clinic 
Thirteen women had concomitant genital ulcers, three at Boomstreet and 10 at Umlazi D. At 
both clinics, one third of these had a positive PCR for HSV-2: one out of three in Boomstreet 
and three out of ten in Umlazi D. One case of LGV was diagnosed at Umlazi D. Nine out of the 







The study presented here compares prevalence of the different causes of vaginal discharge 
syndrome of women attending two different clinics. Boomstreet clinic is situated at a taxi rank 
and will therefore be attended by patients from the area around the clinic as well as commuters 
from different parts of KwaZulu-Natal. Umlazi D clinic is situated in a semi-urban area with a 
stable population. The prevalence of N. gonorrhoeae and T. vaginalis was found to be 
significantly higher in Boomstreet clinic. Chlamydia infections have a more chronic nature as 
do HIV and HSV infection. The prevalence of the first two was similar in both clinics while 
HSV infections were seen with a slightly higher frequency at Umlazi D. For patients, there will 
be a direct link between the symptoms of infection with N. gonorrhoeae or T. vaginalis and 
sexual activity outside a stable relationship. Therefore, medical assistance would not easily be 
sought at the clinic in the area where people live. This may explain why these two infections 
are more prevalent in patients attending the clinic at the taxi rank. 
Over the years many studies have been published addressing the prevalence of sexually 
transmitted infections in women. The results of eight studies conducted in KwaZulu-Natal over 
a period of 26 years are summarized in table 2. 

































n= 193 140 271 189  
245 242 2236 
N. 
gonorrhoeae 
6 6 8 4 12 7 5 3 
C. 
trachomatis 
11 6 13 7 15 11 4 11 
T. vaginalis     36 32 20 10 
BV     28 29 53  
Reference 
number 
(9) (10) (11) (12) * * (13) (14) 
*Personal communication 2017, Prof A.W. Sturm – unpublished data 
Prevalence indicated as percentage  
 
Although the cohorts studied differ in the reason why they attended a healthcare clinic, the 
prevalence rates are similar. In the current study Infections with N. gonorrhoeae in Umlazi 
have the same prevalence as in the STD clinic in KwaMsane in 1999 but in Boomstreet clinic 
this is significantly higher. Whether this indicates that gonorrhea is on the rise needs to be 
established urgently. This is especially important if one takes into account the reports on cases 
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with 3rd generation cephalosporin resistant gonococci,[15-16] since ceftriaxone is currently 
used in the SM protocols. The prevalence of chlamydia infections has remained stable 
throughout the years while trichomoniasis seems to be decreasing. However, this might be a 
misrepresentation since the last two studies in table 2 have not been done in symptomatic 
patients.  If we add the results of the study presented in this paper, then it seems that the 
prevalence of BV is increasing. Mhlongo et al, (2010) report prevalences of the same 
magnitude in patients with symptomatic STDs in Cape Town and Johannesburg with the 
exception of trichomoniasis which is with 36 % higher in Johannesburg than anywhere else.  
Our study was not designed to elucidate the aetiology of genital ulcers. We only performed 
diagnostic tests when an ulcer was detected in a woman with vaginal discharge. We detected 
HSV2 in 4 of the 13 patients with ulcers while 9 had no detectable pathogen. This suggests that 
these were also genital herpes cases. The detection of one patient with chlamydia in the ulcer 
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Purpose: The basis for laboratory diagnosis of bacterial vaginosis (BV) remains microscopy. 
We aimed to identify by microscopy the bacterial morphotypes most frequently observed and to 
quantify these genera by QPCR. Additionally we looked at the vaginal immune response at the 
time of collection and related this to the Nugent’s score and bacterial quantities. 
Methods: Based on Gram stain microscopy, participants were grouped according to Nugent’s 
criteria. Genera representing the most frequently observed morphotypes were quantified by real 
time PCR (RT PCR). Immune cells from vaginal tampon specimens were analysed using flow 
cytometry. Statistical analysis was performed using STATA version 13.1. 
Results: The Nugent score group 0-3 was dominated by Lactobacillus spp. while the Nugent 
score group 7-10 was dominated by Gardnerella vaginalis. The quantity of both organisms was 
significantly higher than all other genera in their respective score groups. The group with 
Nugent score 7-10 was shown to have significantly higher levels of immune cells that are 
proposed HIV targets. 
Conclusion: Gardnerella vaginalis was found to dominate the group with Nugent score 7-10.  
This correlates with an immune response that favors HIV transmission. We found that in 





















Sexually transmitted diseases (STDs) increase the risk of HIV transmission. Although bacterial 
vaginosis (BV) is not considered a STD, it was shown that there was an association of BV with 
increased HIV transmission,[1,2].  HIV target cells include Langerhans (LH) cells, non-LH 
dendritic cells and macrophages. It is thought that HIV interacts with these cells in different 
ways under different conditions to promote viral spread,[3-4]. Determining the differences and 
changes from a healthy vaginal state to a BV state is paramount to unravelling the complicated 
relationship between the microbes that colonize the vaginal mucosa, mucosal immune cells and 
HIV transmission.  
For many years the diagnosis of BV is made clinically using Amsel’s criteria,[5] or 
microscopically by means of Nugent’s scoring system,[6]. The perceived role of Gardnerella 
vaginalis in the aetiology of BV has varied over the years. After its first description in the early 
1955,[7] it was thought to be the single causative agent of BV. Later, its role was questioned 
since the organism was also found in women without this condition. More recently molecular 
techniques identified a diverse group of bacteria associated with BV,[8-9] 
Bacterial vaginosis is a condition in which the vaginal microbiome is altered. The immune 
response of which is seen as vaginal inflammation and the presence of vaginal discharge. 
However, some patients remain asymptomatic. The vaginal flora in healthy women has an 
abundance of Lactobacillus that produce L-lactic acid which inhibits many other microbial 
species,[10]. Lactic acid production also decreases HIV transmission by trapping the virus in 
acidic mucus,[11]. BV is characterized by a decreased concentration of lactobacillus in the 
vagina and an increase of diverse microbial species. However, the cause of BV still remains 
unclear. Recent publications have identified a distinctly different vaginal microbiome in South 
African women where Lactobacillus species dominate only in a minority of asymptomatic 
individuals,[12]. 
Microscopy is the hallmark for laboratory diagnosis of bacterial vaginosis. Our study aimed to 
identify by microscopic observation, differences in bacterial morphotypes in patients presenting 
with vaginal discharge syndrome. Using molecular techniques we determined the relative 
quantities of the microscopically most frequently observed bacteria. We also measured the 




Specimen collection and preparation 
One hundred and sixty one consenting patients of 18 years and older presenting with vaginal 
discharge were recruited at a primary healthcare clinic in Umlazi-Durban, South Africa. 
Patients were treated syndromically and no follow up was done. Diagnostic testing of common 
STIs were performed. Patients with a genital ulcer were tested for the etiological agents of this 
syndrome. Those positive were excluded. A total of 122 tested negative for Chlamydia 
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trachomatis, Neisseria gonorrhea and Trichomonas vaginalis. These 122 patients were 
included in this study. 
 Specimens were collected from all 161 women recruited. 
A standard dacron swab on a rigid shaft was inserted approximately 5 cm into the vagina and 
withdrawn while rotating. Once removed the swab was rolled onto a glass slide to prepare a 
smear for microscopic analysis. 
A vaginal applicator tampon (Tampax® Regular) was inserted into the vagina, removed after 
approximately  1 minute and placed in 10 ml phosphate buffered saline (PBS, pH 7.2) for 
transport [13].  
Upon arrival in the laboratory, the tampon fluid was expressed using an autoclaved wooden 
tongue depressor. The average yield was 6.5 ml. One ml of this was stored at -20oC for DNA 
isolation. The remaining fluid was centrifuged at 1600 rpm for 10 min. The supernatant was 
removed and the pellet was re-suspended in the remaining 1 ml of fluid and prepared for flow 
cytometry.  
Microscopy 
The vaginal smear was gram stained, viewed under light microscopy at 1000x magnification 
and scored using Nugent’s criteria, [6]. A blinded reading of all slides was performed by 2 
trained laboratory personnel. Patients were classified based on the dominant bacterial 
morphotype. 
Flow cytometry 
Each cell suspension was split into four 250 µl aliquots. Each aliquot was centrifuged at 1600 
rpm for 10 min. The supernatant was removed and the cell pellet of three of the four aliquots 
was stained with one of the panels of fluorochrome conjugated antibodies (Table 1). The fourth 
pellet was used as a control for auto-fluorescence. Samples were run on the 












Table 1: Cell markers used for flow cytometry 
Panel 1 
Marker Population 
CD3 T cells 
CD14 Macrophages 
CD11b Monocytes 
CD11c Dendritic Cells (all DC subsets express this marker) 
CD207 Langerhans Cells  (skin resident DCs) 
CD209 Non-LH dendritic cells (DC-SIGN carriers) 
Panel 2 
Marker Population 
CD3 T cells 
CD11b Monocytes 
CD11c Dendritic Cells (all DC subsets) 
CD19 B cells 
CD80 co-stimulatory molecule expressed on activated B-cells, DCs and monocytes 
CD86 co-stimulatory molecule expressed on activated B-cells, DCs and monocytes 
Panel 3 
Marker Population 
CD3 T cells 
CD4 T helper cells 
CD8 Cytotoxic T cell 
CD19 B cells 
CD16 NK cells 
CD56 NK cells 
 
Real Time Quantitative PCR (QPCR)  
Lactobacillus jensenii, (ATCC®25258TM), Gardnerella vaginalis, (ATCC®14018 TM), 
Veillonella parvula, (ATCC®17745 TM) and Prevotella intermedia, (ATCC®25611TM) were 
used as representatives of the morphotypes that were most frequently observed. These reference 
strains were grown on suitable media and the yield was suspended in 1 ml of PBS, pH 7.2, to 
obtain a turbidity of OD 0.5 (600 nm),[14].  
DNA was extracted from 1 mL of tampon fluid from each patient as well as from the reference 
strain suspensions. Fluids and suspensions were centrifuged at 3000g and the deposits were re-
suspended in 200µl PBS, pH 7.2. This was followed by extraction using the QiaAmp DNA 
mini kit, (Qiagen). 
QPCR was performed on the ABI 7500 Real Time PCR system using the Sybre green absolute 
quantitation program. Sequences of the genus specific primers and the annealing conditions 
were taken from previously published studies,[14–16]. The Fast start essential DNA Green 
Master (Roche Diagnostics) was used to prepare the mastermix as per manufacturer’s 
guidelines. The relative percentage of each bacterial type was determined for each sample. 
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Statistical Analysis  
Medians and interquartile ranges (iqr) were used to summarize bacterial load.  The non-
parametric Wilcoxon signed rank test was used to compare bacterial loads done on the same 
woman. The Kruskal-Wallis test was used in the analysis of immune marker distribution 
between the three Nugent’s defined groups with the Bonferonni adjustment for pairwise 





The relative quantities of the four genera of bacteria tested are shown in figure 1 for each of the 
3 Nugent score groups. 
Lactobacillus spp. dominated in the group with 0 to 3 scores. The group scoring 7 to 10 was 
dominated by G. vaginalis. The relative quantities of both bacterial types were significantly 
higher than that of the other three genera in their respective groups, (Fig. 1). The intermediate 
group (score 4 to 6) had elevated levels of all genera when compared with the 0-3 group, except 
for Lactobacillus spp. However, the differences observed did not reach statistical significance. 
 
Figure 1: Relative percentage of microbial DNA associated with BV in each of the 
Nugent's groups 
The relative percentage of genus specific DNA is plotted for each genus tested in the different 
Nugent’s score groups. The median percentage is shown as the horizontal line. Nugent score 0-
3:Lactobacillus spp  compared to Veillonella spp (p=0.0002), Gardnerella vaginalis(p=0.02) 
and Prevotella spp (p=0.05). Nugent score 7-10: Gardnerella vaginalis compared to 
Lactobacillus spp (p=0.03), Veillonella spp (p<0.0001) and Prevotella spp. (p=0.007) 
 
The relative bacterial load of two of the four bacterial genera showed an association with the 
Nugent score, (Fig. 2). The amount of Lactobacillus spp. decreased and that of Gardnerella 






Figure 2: Bacterial profile across the Nugent's groups 
The log of the relative median percentage is plotted for each genus in the different Nugent 
score groups. Spearman’s correlation between Lactobacillus and Nugent score group 7-10 (rs= -
0.17), Gardnerella and Nugent score group 7-10 (rs= 0.3)  Veillonella and Nugent score group 
7-10 (rs= 0.02) and Prevotella and Nugent score group 7-10 (rs= -0.05) 
 
 
Association between vaginal immune cells, Nugent score and dominant bacterial genus 
 
The distribution of the cell markers in the three groups according to the Nugent score are 
shown in Fig. 3 (a). The percentage of NK cells (p<0.02), Langerhans (p<0.04), non-LH 
dendritic cells (DC SIGN carrier)(p<0.02), monocytes(p<0.003) and activated macrophages 
(p<0.009) in the group with Nugent score 7-10 were significantly higher compared to the group 
with score 0-3.  
Figure 3(b) shows the percentages of immune cells in patients grouped according to dominant 
bacterial genus. Dominance was defined as the highest relative percentage observed by PCR in 
each patient. The group dominated by G. vaginalis had a significantly higher percentage of 
activated B cells (p<0.005), NK cells (p<0.0001), Langerhans cells (p<0.0001), non-LH 
dendritic cells (DC SIGN carrier)(p<0.0001) and macrophages (p<0.003) when compared to the 





Figure 3: Immune response of patients within the Nugent's group 
The bars represent the median percentage of each immune cell population tested. 3A shows the 
immune cell populations by Nugent score group and 3B by dominant bacterial genus. L = 




Our study population consisted of women with abnormal vaginal discharge in which no known 
STI etiology could be established with our panel of PCRs. In this group we looked for 
correlations between Nugent score, dominant bacterial genus and mucosal immune cell 
populations. Mycoplasma genitalium was not part of our PCR panel. Therefore some women 
may have had an infection with this organism. 
In keeping with the literature we found Lactobacillus spp. to be the dominating bacterial type in 
the group with the lowest Nugent score. Originally, G. vaginalis was thought to be the 
causative agent of BV. With advancement in molecular detection techniques, several other 
bacterial species were proposed as possible etiological agents. The putative role of G. vaginalis 
was thus diminished. Our cohort of symptomatic women in the group with Nugent score 7 to 10 
was found to be dominated by G. vaginalis. The relative amount of Prevotella spp. remained 
constant throughout the Nugent score. The relative amount of G. vaginalis showed a significant 
upward trend with increasing Nugent score, (p=0.0007). Veilonella spp. showed a trend similar 
to G. vaginalis but at a much lower level (Fig 2).  
In the Nugent score group 4-6 the relative concentration of G.vaginalis starts to change from 
second lowest to highest when score 7-10 is reached. This correlates with a significant drop of 
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the relative concentration of Lactobacillus spp. from Nugent score 0-3 to Nugent score 4-6. The 
decline in levels of inhibitory factors associated with Lactobacillus such as maintenance of a 
low pH by production of lactic acid and the production of H2O2[17] may provide an 
opportunistic environment for multiplication of other bacterial species. G. vaginalis seems to 
make better use of this changing environment than Prevotella spp. or Veillonella spp. Another 
option is that the exponential increase in G. vaginalis concentration drives the change in 
Nugent score and the depletion of Lactobacillus spp.  
Several authors postulate a synergistic relationship between G. vaginalis and the multiple 
anaerobic species present in the vagina during BV,[18-19]. One study showed that Prevotella 
bivia produces ammonia in peptone enriched VDM (vaginal defined medium) which was used 
by G. vaginalis for the production of amino-acids. They postulated that these amino-acids 
stimulated the growth of other anaerobic species [19]. We did not find an increase of Prevotella 
spp. with increase Nugent score. However, the relative percentage of Prevotella spp. remained 
constantly high which may be in keeping with the provision of ammonia to stimulate growth of 
G. vaginalis. The increase in Veillonella spp. relative percentage which starts at mid-level 
Nugent scores could be the result of growth stimulation due to amino-acid production by G. 
vaginalis. This interplay between species may be responsible for increase in pH with 
subsequent inhibition of Lactobacillus spp. 
Despite the frequent microscopic observation of Veillonella morphotypes, at the DNA level 
Veillonella species was present at the lowest levels of the four species tested. This suggests that 
the gram negative cocci observed belonged to different species. While there is no recognised 
causative agent for BV it is agreed that this condition is characterised by the presence of a 
polymicrobial microbiome. While it is generally accepted that predominance of lactobacilli is 
compatible with a healthy vaginal environment, studies on the vaginal microbiome of South 
African women without abnormal vaginal discharge showed that Lactobacillus spp. is not 
always dominant in the vagina of ‘healthy’ patients,[12]. Additionally, those that had 
lactobacillus dominance, differ by species with either Lactobacillus crispatus or Lactobacillus 
iners,[20].  The differences in the dominant bacterial type of a ‘healthy vaginal state’ seen in 
South African women are reflected in the commensal bacteria present. Table 2 shows a 
comparison of bacterial colonization between this study in symptomatic women and the study 
by Anahtar et al,[12]. The only statistically significant difference between symptomatic and 
asymptomatic women was a higher percentage with mixed flora in the asymptomatic group. 
This is likely based on differences in study design. Application of next generation sequencing 










Table 02: Comparison of bacterial load between asymptomatic and symptomatic patients 
The study cohort of this study was grouped to match data accordingly. Lactobacillus 
dominance = CT1+2, Gardnerella dominance = CT3 and mixed species = CT4 
 
  
The vaginal immune response to bacteria and the ability to initiate an inflammatory response or 
induce chemotaxis has major importance in disease and health. A number of studies have 
shown that Lactobacillus associated with a healthy vagina or lactic acid produced has little or 
no effect on inflammatory response,[21]. Contrary to this, bacteria associated with BV and 
short chain fatty acids produced by these anaerobes do stimulate an inflammatory 
response,[22]. We found that increase in Langerhans cells; non-LH dendritic cells and 
macrophages were associated with dominance of gardnerella. The Anahtar study,[12] in 
asymptomatic patients found in the gardnerella dominant group a trend towards increased 
cytokine levels that are produced by the cells that we found significantly elevated in 
symptomatic women with gardnerella dominance. This suggests that G. vaginalis initiates an 
immune response the level of which determines whether a women is symptomatic or not.   
This is supported by our finding that there is a significantly higher expression of NK cells, 
Langerhans cells, non-LH dendritic cells, monocytes and activated macrophages in the BV 
group compared to the group with the lowest Nugent score. The latter was dominated by 
Lactobacillus spp. while the BV group was dominated by G. vaginalis. 
A recent in vitro study showed a dose dependent relationship between G. vaginalis and 
stimulation of an immune response. This resulted in maturation of dendritic cells and reduction 
in internalization capacity,[23]. Characteristics associated with virulence of G. vaginalis are the 
ability to form biofilms,[24]and the production of a cytolysin. It has been postulated that its 
virulence is increased by synergistic interaction with other BV associated bacteria. An example 
of this is the sialidase of Prevotella species and Bacteroides species that break down mucus and 
so allowing better adhesion of G. vaginalis to the vaginal epithelium. High vaginal levels of 
sialidase also prevented an IgA response to G. vaginalis cytotoxin, thereby mitigating the 
immune response, [25].  
There is an association of increased HIV expression and transmission in BV patients,[1]. Our 
study shows a significantly higher number of HIV target cells (Langerhans, DC-sign and 
macrophages) in the BV group and the group dominated by Gardnerella spp.  Langerhans cells 
infected with HIV have the ability to travel to the lymph nodes disseminating the virus. The 
observation of a significantly higher number of monocytes in the BV group shows the potential 
for BV associated stimuli to promote differentiation to macrophages or dentritic cells. We show 
that populations dominated by Gardnerella vaginalis have an increased expression of 
macrophages when compared to Lactobacillus spp. dominant groups.  
  Number (%) with   
  Anahtar et al this study p-value 
Lactobacillus dominance 54 (37%) 66 (41%) 0.5 
Gardnerella dominance 41 (28%) 59 (37%) 0.1 
mixed species  51 (35%) 36 (22%) 0.02 
Nugent score 7-10 73 (50%) 79 (49%) 0.9 
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Increased concentrations of Gardnerella vaginalis was associated with increased vaginal 












Detection of vaginal HSV-2 shedding has been associated with increased vaginal HIV RNA 
copies. Bacterial vaginosis (BV) is implicated in the transmission of HIV. Patients with BV 
have been shown to increase the frequency of HSV-2 shedding. 
Methods 
Consenting symptomatic female patients >18 years were recruited from a primary healthcare 
clinic (PHC) in Durban. Serological tests to detect HSV-2 and HIV were performed. Vaginal 
bacterial concentrations and HIV viral loads were determined by QPCR. Conventional PCR 
was done to ascertain which patients were shedding HSV-2 at the time of collection. 
Results 
Lactobacillus spp. was associated with the group that was HIV antibody negative and 
Prevotella spp with the HIV antibody positive group (p < 0.05). Prevotella spp. was not 
associated with shedding of HIV.  The bacterial copies of Gardnerella vaginalis was higher in 
patients shedding HSV-2 and significantly higher copies in those shedding HIV, (p < 0.05). 
Conclusions 
This study emphasizes the role of BV in the transmission of HIV. We show that G. vaginalis 

















Bacterial vaginosis (BV) is associated with HIV infection. Several studies have shown that 
mixed vaginal bacterial populations result in higher concentration of HIV 1 RNA in the 
endocervix.1,2 In vitro studies have shown that the cervicovaginal mucus from Lactobacillus 
dominant  women have a protective effect against HIV infection.3 During BV there is increased 
diversity of anaerobic bacterial species. Succinic acid, a metabolic product of a variety of 
anaerobic bacterial species associated with BV, was found to increase HIV expression in HIV 
infected monocyte derived macrophages.4 
Upregulation of pro-inflammatory cytokines has been reported in women with high Nugent 
scores irrespective of the presence of symptoms associated with BV. In the same study, it was 
found that cytokine concentrations were much lower during HSV shedding and Trichomonas 
vaginalis infection.5 HSV 2 infection and in particular vaginal shedding of HSV, is associated 
with both the acquisition and shedding of HIV RNA.6–8 A Gram stain score compatible with 
bacterial vaginosis was found to increase the frequency  of HSV shedding in HSV-2 
seropositive women.9 A bacterial microbiome associated with BV elicits a pro inflammatory 
response which is capable of disrupting the epithelial barrier function.10 This increases the risk 
of infection with bacterial STIs, HSV-2 and HIV. 
This study aimed at exploring the association of the bacterial morphotypes most frequently 




Consecutive consenting patients presenting with vaginal discharge were recruited on weekdays 
between 8:00 am and 12:00 from October till December 2014 at the Umlazi D clinic in Durban, 
KwaZulu-Natal, South Africa. Ethical approval was obtained from the Biomedical Research 
Ethics Committee – University of KwaZulu-Natal. 
A Dacron swab was inserted for approximately 5 cm into the vagina and withdrawn while 
rotating. Following this, a vaginal tampon (Tampax® regular) was inserted and left for 1 
minute. On removal the tampon was placed into 10 mL PBS (pH7.0).11 Approximately 4 ml of 
clotted blood was collected by venapuncture. 
Smears for microscopy were prepared by rolling the vaginal swab onto a glass slide followed 
by Gram staining. Bacterial colonization was assessed using Nugent’s score criteria. 
Upon arrival in the laboratory, the tampon fluid was expressed using an autoclaved wooden 
tongue depressor. The average yield was 6.5 ml. One ml of this was stored at -20oC for DNA 
isolation. The remaining fluid was centrifuged at 500g for 10 min. The supernatant was 
removed and stored at -20oC for HIV quantitative PCR.   
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Clotted blood was centrifuged at 1500g for 10 min following which the serum was used for 
HIV antibody testing with the one step HIV rapid kit (CORETM, Beijing, China) as per 
manufacturer’s recommendations. HIV antibody tests were performed on tampon fluid of those 
patients that refused venipuncture. 
Lactobacillus jensenii, (ATCC®25258TM), Gardnerella vaginalis, (ATCC®14018 TM), 
Veillonella parvula, (ATCC®17745 TM) and Prevotella intermedia, (ATCC®25611TM) were 
used as representatives of the morphotypes that were most frequently observed. All reference 
strains except Gardnerella vaginalis were grown on brain heart infusion (BHI) agar 
supplemented with 5% yeast extract, 5mg/l heamin and 1mg/l menadione. Gardnerella 
vaginalis was grown on BHI supplemented with 10% heat inactivated horse serum. The yield 
was suspended in 1 ml of PBS, pH 7.2, to obtain a turbidity of OD 0.5 (600 nm).12 
DNA was extracted from 1 mL of tampon fluid from each patient as well as from the reference 
strain suspensions. Fluids and suspensions were centrifuged at 3000g and the deposits were re-
suspended in 200 µl PBS, pH 7.2. This was followed by extraction using the QiaAmp DNA 
mini kit, (Qiagen, Hilden, Germany). 
QPCR was performed on the ABI 7500 Real Time PCR system using the Sybre green absolute 
quantitation program. Sequences of the genus specific primers and the annealing conditions 
were taken from previously published studies,12–14. The Fast start essential DNA Green Master 
(Roche Diagnostics, Indianapolis, USA) was used to prepare the mastermix as per 
manufacturer’s guidelines. The relative percentage of each bacterial type was determined for 
each sample. 
A conventional PCR to detect the presence of HSV-2 DNA was performed on the ABI 9700 
thermal cycler. Primer sequences and cycling conditions were as previously published.15 
Two milliliters of the cell free supernatant was centrifuged at 15 000 rpm for 3 hours at 4oC. 
Most of the supernatant was discarded and the pellet was re-suspended in the remaining 140 µl. 
The Qiamp viral RNA extraction kit (Qiagen, Hilden, Germany) was employed as per 
manufacture’s guideline resulting in a final elution volume of 100µl. The commercially 
available HIV Real-TM Quant kit (Sacace Biotechnologies, Lombardia, Italy) for the 
quantitative detection of HIV was used.  
QPCR was performed on the ABI 7500 Real Time PCR instrument. Standards were run in 
duplicate for each run. Internal controls (IC) contained in the kit were added to each sample 
prior to extraction. This controlled for loss during extraction and inhibition of PCR in the 
calculation of viral quantity. The concentration of HIV RNA was calculated using the given 
formula: 
HIV DNA copies/specimen 
_________________________ X coefficient = copies HIV/mL 
 
IC DNA copies/specimen 
 
The coefficient is specific for each lot and is reported on the data card within the kit. 
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Statistical Analysis  
Medians and interquartile ranges (iqr) were used to summarize HIV and bacterial loads.  The 
non-parametric Wilcoxon signed rank test was used to compare viral and bacterial loads done 




A total of 161 patients were recruited of which 79 patients were found to be positive for HIV 
antibodies, 30 on serum and 49 on vaginal fluid.  Sixteen (20%) of these 79 patients were 
shedding HSV-2 while the remaining 63 did not shed this virus at the time of collection. 
Vaginal shedding of HIV was detected in 10 and 32 HSV-2 shedders and non-shedders 
respectively. The median vaginal HIV viral load in the group that shed HSV-2 was 11650 
































Figure 1: Vaginal HIV viral load in patients simultaneously shedding HSV-2 and in patients 
who were not shedding HSV-2. Median and interquartile range are represented graphically 
Of the 161 patients enrolled, 122 had no detectable sexually transmitted infections other than 
BV. On Gram stain microscopy four bacterial morphotypes were most frequently observed. 
QPCR for the genera representing these four morphotypes were performed on tampon fluids of 
all women enrolled. In the 122 without STIs, Lactobacillus species was found to have the 
highest relative concentration in the group with Nugent score 0-3 while the percentage of 
Gardnerella vaginalis was highest in the group with Nugent score 7-10. The 4-6 group had an 
almost even mix of the bacterial genera tested with no statistical differences observed between 
genera except for Veillonella spp. which relative percentage was statistically lower than that of 































































































































































Figure 2: Aligned dot plot showing the relative percentage of 4 defined vaginal bacteria 
stratified by Nugent’s score groups. Median and interquartile range are represented graphically. 
 
There was a trend to higher relative concentrations of Prevotella spp. in the HIV antibody 
positive group while more Lactobacillus spp. were found in the HIV antibody negative group. 
However, none of these differences reached statistical significance (Table 1). In the 56 HIV 
antibody positive patients, the relative concentration of Gardnerella vaginalis was highest in 
women that also shed HIV in the vaginal secretions (p=0.02). Contrary to this Prevotella spp. 
was significantly associated with non HIV shedding, (p=0.02) (table 1). There was a greater 
median bacterial load of Lactobacillus spp. Veilllonella spp. and Gardnerella spp. in the group 
that shed HSV-2 in the vaginal secretions compared to the group that did not, (table 1). The 
latter observation is the same for the 66 HIV antibody negative patients, except for Veillonella 








Table 1: Relative concentration of bacteria in patients shedding HIV and HSV-2 
Median percentage of bacterial genus represented with (iqr). Significance observed at p ≤0.05 
                                                Median (iqr) 
  Lactobacillus Veillonella Prevotella Gardnerella 



































(97.44) 7.39 (40.31) 










p-value HSV-2 shedders vs HSV-2 non 




In the group that tested positive for sexually transmitted infections (Neisseria gonorrhoea, 
Trichomonas vaginalis, Chlamydia trachomatis, Treponema pallidum and Haemophilus 
ducreyii), Prevotella spp. had the highest relative concentration in the group with Nugent’s 
score 0-3. However, no significant differences were observed between the Nugent score groups. 
Lactobacillus spp. was highest in women with Nugent score 4-6, while Gardnerella vaginalis 
was highest in those with Nugent score 7-10. Although statistical differences were observed 
between Lactobacillus spp. and Veillonella spp. in the Nugent score group 4-6 and between 
Gardnerella and Prevotella/Veillonella in Nugent score  group 7-10 , none of the bacteria 




Several reports link shedding of HSV-2 with increased HIV transmission.16,17 It has been shown 
that increased levels of cervical HSV-2 shedding were associated with the presence of 
increased cervical HIV RNA concentrations.18 In keeping with the literature we report a higher 
HIV viral load in patients shedding HSV-2 compared to those that were not. Failure to reach 
statistical significance is likely because analysis was limited to the 79 HIV positive patients. 
BV has been implicated as a risk factor for the transmission of HIV. This is thought to be a 
result of changes in pH brought on by disruption of the H2O2 producing Lactobacillus dominant 
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environment seen in healthy women.10 We show that the intermediate group (score 4-6) and the 
BV group (score 7-10) had higher median number of HIV copies than the group with score 0-3. 
The intermediate group had the highest vaginal HIV viral load though this did not reach 
statistical significance. Molecular analysis of 4 bacterial genera confirms the presence of a 
Lactobacillus dominant community in the women with a 0-3 Nugent score and was associated 
with the lowest level of HIV shedding. The intermediate group showed a drastic decline in the 
relative percentage of Lactobacillus spp. allowing for the increased bacterial diversity. In 
addition there were no statistical differences in relative percentages between the genera in the 
intermediate group except for Veillonella spp. which was lower than the other genera. A 
limitation of our approach is that we tested for only four genera. Including more species could 
change this picture. 
Individuals infected with HIV have enteropathy with increased inflammation.19 Gut flora rich 
in Prevotella spp. has been associated with HIV infected individuals.20 Another study on South 
African females reported the highest vaginal inflammatory response in patients with greater 
than 1% Prevotella bivia which increases inflammation by the release of lipopolysaccharide 
(LPS). This inflammatory response increases the likelihood of becoming infected with HIV.21 
In this study Veillonella spp. and Prevotella spp. had higher relative percentage in the HIV 
antibody positive group with Prevotella spp. reaching statistical significance.   
Within the HIV antibody positive group, Gardnerella vaginalis and Veillonella spp. were 
associated with the group that shed HSV-2. Previous studies have reported an association 
between cervico-vaginal shedding of HSV-2 with increased genital HIV RNA and DNA.17 
We report a negative association between Prevotella spp. and HIV shedding while Gardnerella 
vaginalis showed a positive association.  Additional logistic regression based on grouping 
bacteria by dominance (Lactobacillus spp. Gardnerella vaginalis and mixed species 
(Veillonella and Prevotella)), the odds of HIV shedding was 4.5X greater in the group 
dominated by Gardnerella vaginalis (OR: 4.5: 95%CI 1.13-17.99) when compared to 
Lactobacillus dominance. In our study population, vaginal environments dominated by 
Gardnerella vaginalis were found to have significantly elevated levels of immune cells. . These 
included macrophages, Langerhans cells and non- Langerhans denditric cells (DC-SIGN 
positive) which are targets for HIV infection.  
This study indicates a role of BV in the transmission of HIV and HSV-2 and we show that this 
is related to the concentration of G. vaginalis in the vaginal content but not to the concentration 
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DISCUSSION AND CONCLUSION 
 
In this study patients were recruited from two different PHCs in KZN. One of which is situated 
near a taxi rank close to the central business district in the capital city of KZN  and the other in 
a township away from the Durban CBD. We found the prevalence of vaginal discharge 
pathogens significantly higher in the clinic close to the taxi rank as opposed to the township. 
Two of the three pathogens cause acute infections and the accompanying symptoms of the 
disease point to the presence of a STI and relate to sexual behavior. Therefore patients are 
likely to travel to PHCs away from their residence for treatment. The clinic in the township had 
more patients with BV and HSV, which are more chronic conditions. 
Of the patients with ulcers, HSV-2 was observed in 4 of 13 patients and 1 patient was 
diagnosed with LGV. However, 69% (9/13) had no detectable aetiology. In 1991 the 
assessment of genital ulcers in women reported a higher frequency of ulcers of which bacterial 
aetiology was the main cause. HSV was detected in 18% while another 18% had no 
aetiology,(O’Farrell et al. 1991). While we report a fewer number of ulcers, the majority 
remains without aetiology and HSV-2 remains the most detected pathogen.  The study by 
Leichliter et al, (2016), in South African men, found of the ulcers that had detectable aetiology, 
HSV -2 was the most prevalent (71.4%). Bacterial aetiology was found less frequently, in 
20.8% there was no pathogen identified,(Leichliter et al. 2016). We observed fewer ulcers in 
our population; this is due to the recruitment of women with a discharge of which ulcers were a 
secondary observation.  
In both clinics BV had the highest prevalence; this was followed by T. vaginalis infection. This 
finding is supported by the study of Mlisana et al. 2012  in  high risk women in Durban, KZN. 
The combined prevalence of N. gonorrhoeae from the Boomstreet and Umlazi clinic was 
14.2% (93/625). We report a prevalence range from 3% to 12% in the studies described in table 
2 of the manuscript titled: “Prevalence of sexually transmitted diseases in women in KwaZulu-
Natal”. There is an increase in the number N. gonorrhoeae infections but this is not significant. 
However, our study was in symptomatic patients and most of the studies quoted in table 2 were 
not. While there are no observed differences in prevalence for C. trachomatis and T. vaginalis, 
prevalence of BV has increased. 
Gardnerella vaginalis  plays a role in the pathogenesis of BV 
We found in women with vaginal discharge syndrome that the prevalence of BV was higher 
than that of infection with any of the STI pathogens. The causative agent of BV has to date not 
been established. The condition is described as a polymicrobial state in which there is a 
reduction of Lactobacillus spp. and an increase in anaerobic bacteria,(Fredricks et al. 2005). A 
vaginal microbiome that is dominated by Lactobacillus spp. is thought to prevent HIV and 
many urogenital infections including bacterial vaginosis and STIs by the production of lactic 
acid which lowers the vaginal pH, (Lai et al. 2009; Wiesenfeld et al. 2003).  Although in 1955 
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G. vaginalis was thought to be the etiological agent of BV, the discovery of unculturable 
microbes associated with the condition have identified these as possible pathogens, (Gardner & 
Dukes 1955; Fredricks et al. 2005). This was further supported by the isolation of G. vaginalis 
from women without BV,(Aroutcheva et al. 2001). However, this holds true for recognized STI 
pathogens since all of these do cause asymptomatic infections.  
Microscopy still remains the most commonly used method for laboratory diagnosis of BV.  We 
quantified 4 of the most frequently observed morphotypes by QPCR. In keeping with the 
literature we found that Lactobacillus spp. dominated the group with low Nugent score while 
G. vaginalis dominated the group with high Nugent scores. Although G. vaginalis was also 
detected in the women with lower Nugent scores, the quantity detected increased with 
increasing Nugent score. This trend was also observed with the genus Veillonella spp. but the 
increase in number of copies did not reach statistical significance. Prevotella spp. remained 
relatively constant in all three Nugent score groups.  Bradshaw et al, (2006), reported an 
increasing concentration of Atopobium vaginae with rising Nugent score with a significantly 
higher copy number detected in the 7-10 group. They describe the same trend for G. vaginalis. 
A. vaginae was found only in combination with G. vaginalis. The latter statement supports the 
role of G. vaginalis in stimulating the growth of other bacterial species associated with bacterial 
vaginosis.  
Prevotella bivia has been reported to support the growth of G. vaginalis and 
Peptostreptococcus anaerobium by production of ammonia and amino acids, (Pybus & 
Onderdonk 1997; Pybus & Onderdonk 1998). The observation of symbiotic relationships 
between bacteria associated with BV supports the presence of a polymicrobial state as 
described in patients with BV. However, the question remains as to what drives the 
establishment of this polymicrobial state.  
For the establishment of any infection it is necessary for sufficient adherence to host cells. 
Tissue culture experiments on cervical epithelial cells showed a greater adherence of G. 
vaginalis and Peptoniphilus spp. as compared to other anaerobes tested. Veillonella spp. and 
Prevotella bivia failed to adhere. In addition, G. vaginalis was capable of producing thicker 
biofilms and was the only species tested capable of cytotoxicity, (Patterson et al. 2010). In 
another in vitro study, G. vaginalis obtained from a patient with BV was able to displace 
Lactobacillus crispatus but not Lactobacillus iners. The strain of G. vaginalis obtained from a 
healthy patient had a minimal effect on both. L. iners also supported the adhesion capacity of 
the BV associated G. vaginalis strain, (Castro et al. 2013).  The previous role of G. vaginalis as 
a pathogen in the condition of BV has been questioned after the advent of techniques capable of 
identifying unculturable bacteria. With every report on increased concentrations of the different 
anaerobes in patients with BV, the importance of G. vaginalis in this condition diminished. 
This study re-examines the role of G. vaginalis, in symptomatic women without the 
complication of an STI. We find that G. vaginalis is the most likely pathogen responsible for 
the condition of BV in this cohort of patients.  
There are distinctly different strains of G. vaginalis, one which remains commensal and is 
detected in healthy patients and one associated with BV. Recurrence of BV is frequently 
reported. Harwich et al, (2010), reported on the resistance of G. vaginalis to several 
antimicrobials and the presence of several genes and proteins which promote antimicrobial 
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resistance. The transfer of resistance genes between bacterial species is well documented, 
(Ochman et al. 2000). This further underscores the importance of BV and treatment thereof in a 
population with a high incidence of STIs and HIV. 
South Africa is plagued with a high prevalence and incidence of HIV. STIs and BV are 
associated with increased HIV transmission. We found in our study a significantly higher 
number of immune cells which serve as HIV targets in the group with BV and the group 
dominated by G. vaginalis. The group with BV had overall significantly higher copy numbers 
of G. vaginalis compared to the other bacteria tested. While the importance of G. vaginalis in 
the transmission of HIV is highlighted, the limitation of this study remains that only 4 genera of 
vaginal bacteria were analysed. The overall sero-prevalence of HSV-2 in our study was 73. In a 
subset of patients with no aetiological diagnosis other than BV for symptomatic vaginal 
discharge, the HIV viral load was higher in those patients that shed HSV-2. This is in keeping 
with McClelland et al, (2002), who showed an association between increased HIV RNA and 
increased HSV copies. G. vaginalis and Veillonella spp. were associated with the group that 
shed HSV-2. Further G. vaginalis was associated with increased HIV shedding.  
In conclusion, this study reflects the high burden of STIs and HIV in women presenting with 
vaginal discharge at 2 PHCs in urban KwaZulu-Natal. We attempted to correlate for the first 
time in symptomatic patients without STI aetiology and ulcer pathogens, the association of BV 
and BV pathogens to vaginal immune response using immune cell differential identification. 
More recent publications on asymptomatic women from South Africa show that Prevotella spp. 
is present in patients with great bacterial diversity. We show a consistent presence of Prevotella 
spp. in all Nugent’s groups. Further, we did not find any statistically significant increases in 
concentration of Prevotella spp. through the Nugent score groups indicating that’s its role in the 
pathogensis of BV is more likely to alter the pH of the environment and by the production of 
metabolites that support the growth of other anaerobes more especially G. vaginalis which 
drives the condition of BV. We also report on an increasing concentration of Veillonella spp 
through the Nugent score group. Although the increase is not statistically significant, it adds to 
the establishment of the polymicrobial state of BV. This study highlights the importance of BV 
associated bacteria in the transmission of HIV. The initiation of a vaginal immune response and 
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Staining for Flow Cytometry 
Centrifuge 1.8ml of cell suspension at 1500rpm (4°C) for 10 minutes 
Remove supernatant leaving 100ul behind 
Add 1ul of each antibody according to panel design 
Vortex and incubate at 2°C-8°C for 20 minutes 
Add 500ul of FACS buffer (1% FBS in PBS) 
Centrifuge at 1500rpm (4°C) for 10 minutes 
Remove supernatant 
Add 200ul fixative (4% paraformaldehyde in FACS buffer) 
 
Culture media for ATCC strains 
Lactobacillus, Veillonella and Prevotella 
Brain heart infusion broth (BHI) supplemented with 5% yeast extract, hemin 5mg/L and 
vitamin K 1mg/L 
Gardnerella vaginalis 
BHI supplemented with 5% yeast extract and 10% heat inactivated horse serum 
 
 
 
 
 
